{"latest_checked": "2026-08-13T04:33:12.746470+00:00", "coverage_count": 5070, "recent_count": 2, "transaction_limit": 160, "filters": {"q": "", "ticker": "XFOR", "sector": "", "industry": "", "side": "", "start": "2026-06-30", "end": "2026-08-14"}, "summary": {"total": 2, "acquisition_count": 1, "disposal_count": 1, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 36428.2063, "disposal_value_label": "$36.4K", "net_value": -36428.2063, "net_value_label": "$-36.4K", "flow_tone": "negative", "largest_value_label": "$36.4K", "top_sector": "Healthcare", "window_label": "30 Jun 2026 to 14 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 2, "value": "36428.2063", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$36.4K"}], "days": [{"transaction_date": "2026-06-30", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}, {"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 100.0}], "side_mix": {"acquisitions": 1, "disposals": 1, "acquisition_share": 50.0, "disposal_share": 50.0}}, "company_flows": [{"symbol": "XFOR", "name": "X4 Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-06-30", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 36428.2063, "disposed_value_label": "$36.4K", "net_value": -36428.2063, "net_value_label": "$-36.4K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/xfor/", "research_links": {"chart": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/", "report": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/report/", "factor": "/factors/ticker/89c37fbb-3f4a-4976-a176-9502b7c64bc5/"}}], "company_overview": [{"symbol": "XFOR", "name": "X4 Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "filings": 2, "acquisitions": 1, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 36428.2063, "disposed_value_label": "$36.4K", "net_value": -36428.2063, "net_value_label": "$-36.4K", "acquisition_share": 50.0, "disposal_share": 50.0, "tone": "Mixed flow", "tone_class": "neutral", "detail_url": "https://sharemaestro.com/insider-activity/company/xfor/", "research_links": {"chart": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/", "report": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/report/", "factor": "/factors/ticker/89c37fbb-3f4a-4976-a176-9502b7c64bc5/"}}], "transactions": [{"symbol": "XFOR", "name": "X4 Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "GOLD, KELLY", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 110000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-22T21:55:18.755865+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/xfor/", "research_links": {"chart": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/", "report": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/report/", "factor": "/factors/ticker/89c37fbb-3f4a-4976-a176-9502b7c64bc5/"}}, {"symbol": "XFOR", "name": "X4 Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "KIRSKE, DAVID", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8543.0, "share_price": 4.2641, "transaction_value": 36428.2063, "transaction_value_label": "$36.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-21T10:45:14.881138+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/xfor/", "research_links": {"chart": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/", "report": "/terminal/89c37fbb-3f4a-4976-a176-9502b7c64bc5/report/", "factor": "/factors/ticker/89c37fbb-3f4a-4976-a176-9502b7c64bc5/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}